TCIM
TIAA CREF Investment Management’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $186K | Buy |
117,938
+68,686
| +139% | +$108K | ﹤0.01% | 2896 |
|
|
2018
Q4 | $57K | Hold |
49,252
| – | – | ﹤0.01% | 2993 |
|
|
2018
Q3 | $182K | Sell |
49,252
-17,695
| -26% | -$65.4K | ﹤0.01% | 2999 |
|
|
2018
Q2 | $205K | Sell |
66,947
-22,505
| -25% | -$68.9K | ﹤0.01% | 3031 |
|
|
2018
Q1 | $348K | Buy |
89,452
+11,942
| +15% | +$46.5K | ﹤0.01% | 2875 |
|
|
2017
Q4 | $348K | Sell |
77,510
-5,244
| -6% | -$23.5K | ﹤0.01% | 2904 |
|
|
2017
Q3 | $453K | Buy |
82,754
+1,339
| +2% | +$7.33K | ﹤0.01% | 2866 |
|
|
2017
Q2 | $618K | Buy |
81,415
+29,704
| +57% | +$225K | ﹤0.01% | 2763 |
|
|
2017
Q1 | $184K | Sell |
51,711
-1,439
| -3% | -$5.12K | ﹤0.01% | 3005 |
|
|
2016
Q4 | $304K | Buy |
53,150
+4,630
| +10% | +$26.5K | ﹤0.01% | 2975 |
|
|
2016
Q3 | $377 | Buy |
48,520
+1,568
| +3% | +$12 | ﹤0.01% | 2950 |
|
|
2016
Q2 | $292K | Buy |
46,952
+25,729
| +121% | +$160K | ﹤0.01% | 3043 |
|
|
2016
Q1 | $174K | Buy |
21,223
+2,410
| +13% | +$19.8K | ﹤0.01% | 3000 |
|
|
2015
Q4 | $326K | Buy |
18,813
+12,979
| +222% | +$225K | ﹤0.01% | 3000 |
|
|
2015
Q3 | $67K | Buy |
+5,834
| New | +$67K | ﹤0.01% | 3085 |
|